Reuters logo
BRIEF-Kitov Pharmaceuticals says signed a license agreement for KIT-302
2017年3月8日 / 下午3点27分 / 6 个月前

BRIEF-Kitov Pharmaceuticals says signed a license agreement for KIT-302

March 8 (Reuters) - Kitov Pharmaceuticals Holdings Ltd

* Kitov Pharmaceuticals Holdings Ltd - has signed a definitive license agreement for its lead product candidate, KIT-302

* Kitov Pharmaceuticals Holdings Ltd - Kuhnil will have exclusive right and license to manufacture, distribute and sell KIT-302 in South Korea

* Kitov Pharmaceuticals Holdings Ltd - Kuhnil will be responsible for seeking regulatory approval for KIT-302 in South Korea

* Kitov Pharmaceuticals Holdings Ltd - commercial launch in South Korea is estimated to take place in 2019

* Kitov Pharmaceuticals Holdings Ltd- under terms of agreement,co is entitled to receive milestone payments and double digit royalties on net sales Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below